Divergent pathways of liver fat accumulation, oxidation, and secretion in lipodystrophy versus obesity‐associated NAFLD
Liver International · 2023
DOI: 10.1111/liv.15707 ↗Kurz gefasst
Fachartikel in der Zeitschrift Liver International, 2023. Verfasst von Rachael J Klein und 3 weiteren Autor:innen. Beteiligte Einrichtung: Section on Translational Diabetes and Metabolic Syndromes, Diabetes, Endocrinology and Obesity Branch, National Institute of Diabetes and Digestive a…. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Insulin Resistance, Lipodystrophy. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases.
Abstract (Originalsprache)
Background and Aims Fatty liver is common in obesity as well as in partial lipodystrophy (PL) syndromes, characterized by deficient adipose tissue. Insulin resistance is key to fatty liver pathogenesis in both entities. We aimed to compare the contributions of insulin resistance and adipose tissue to hepatic steatosis in PL and non‐syndromic, obesity‐associated non‐alcoholic fatty liver disease (NS‐NAFLD).
Methods
In a cross‐sectional comparison of people with NS‐NAFLD ( N = 73) and PL ( N = 27), liver fat was measured by FibroScan ® controlled attenuation parameter (CAP) and insulin resistance by HOMA‐IR, Adipo‐IR, and NMR‐based LP‐IR.
Results
Insulin resistance was greater in PL versus NS‐NAFLD by HOMA‐IR ( p = 0.005), Adipo‐IR ( p = 0.01) and LP‐IR ( p = 0.05) while liver fat was comparable (304 vs. 324 dB/m, p = 0.12). Liver fat correlated with HOMA‐IR in both groups, but CAP values were lower by 32 dB/m in PL compared with NS‐NAFLD for any given HOMA‐IR. In contrast, Adipo‐IR and LP‐IR correlated with CAP only in the NS‐NAFLD group, suggesting different pathways for fat accumulation. Plasma free fatty acids, reflecting substrate input from the adipose tissue, were comparable between groups. However, the levels of β‐hydroxybutyrate, a marker of β‐oxidation, and large triglyceride‐rich lipoprotein particles, a marker of VLDL secretion, were both higher in PL ( p < 0.001 for both).
Conclusion
Liver fat content was comparable in subjects with PL‐associated NAFLD and NS‐NAFLD, despite worse insulin resistance in partial lipodystrophy. Our data demonstrate higher triglyceride oxidation and export in PL, suggesting a compensatory shift of fat from liver storage into the circulation that does not occur in NS‐NAFLD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Section on Translational Diabetes and Metabolic Syndromes, Diabetes, Endocrinology and Obesity Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland,…
- Liver & Energy Metabolism Section, Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA.
ORCID-Profile: Rachael J Klein, Gracia M Viana Rodriguez, Yaron Rotman, Rebecca J Brown
Förderung
- NIDDK NIH HHS
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Klein, R. J., Viana Rodriguez, G. M., Rotman, Y., & Brown, R. J. (2023). Divergent pathways of liver fat accumulation, oxidation, and secretion in lipodystrophy versus obesity‐associated NAFLD. Liver International. https://doi.org/10.1111/liv.15707
Vancouver
Klein RJ, Viana Rodriguez GM, Rotman Y, Brown RJ. Divergent pathways of liver fat accumulation, oxidation, and secretion in lipodystrophy versus obesity‐associated NAFLD. Liver International. 2023. doi:10.1111/liv.15707
BibTeX
@article{Klein2023,
author = {Klein, Rachael J and Viana Rodriguez, Gracia M and Rotman, Yaron and Brown, Rebecca J},
title = {Divergent pathways of liver fat accumulation, oxidation, and secretion in lipodystrophy versus obesity‐associated NAFLD},
journal = {Liver International},
year = {2023},
doi = {10.1111/liv.15707}
}
EUVIMED